1. G.d. Searle & Company (32 from 1,323 patents)

2. Other (9 from 832,718 patents)

3. Pharmacia Corporation (3 from 200 patents)

4. Pfizer Corporation (1 from 4,455 patents)

5. G.d. Searle LLC (1 from 33 patents)

1. 7091319 - IL-3 variant hematopoiesis fusion protein

2. 6916800 - Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent

3. 6858598 - Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia

4. 6833373 - Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia

5. 6730303 - Fused G-CSF and IL-3 proteins and uses thereof

6. 6689787 - Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia

7. 6649645 - Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia

8. 6479261 - Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells

9. 6458931 - Interleukin-3 (IL-3) multiple mutation polypeptides

10. 6451852 - Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives

11. 6440407 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides

12. 6436387 - Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins

13. 6413509 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors

14. 6403076 - Compositions for increasing hematopoiesis with interleukin-3 mutants

15. 6379662 - Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production